Intellia Therapeutics, Inc.
Diagnostics company · Cambridge, Massachusetts, United States · Nasdaq: NTLA
Intellia Therapeutics, Inc. is a diagnostics company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker NTLA. It has reported private securities offerings to the US SEC, most recently $70 million sold in a notice filed in 2015.
Intellia Therapeutics at a glance
What does Intellia Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $70 million sold (2015).
Frequently asked questions about Intellia Therapeutics
Where is Intellia Therapeutics headquartered?
Intellia Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Intellia Therapeutics do?
Intellia Therapeutics, Inc. is a diagnostics company. Its SEC industry classification is In Vitro & In Vivo Diagnostic Substances.
Is Intellia Therapeutics a public company?
Yes. Intellia Therapeutics, Inc. trades on Nasdaq under the ticker NTLA.
When was Intellia Therapeutics founded?
The earliest incorporation on record for Intellia Therapeutics, Inc. is in 2014, according to public company registers.
Similar companies
- Achieve Life Sciences, Inc.Seattle, Washington, United States
- Celldex Therapeutics, Inc.Hampton, New Jersey, United States
- Navidea Biopharmaceuticals, Inc.Dublin, Ohio, United States
- Eyenuk, Inc.Woodland Hills, California, United States
- Lucira Health, Inc.Emeryville, California, United States
- NeuroTrack Technologies, Inc.Redwood City, California, United States
- Biomerica IncIrvine, California, United States
- Meridian Bioscience IncCincinnati, Ohio, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.